BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16352681)

  • 1. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation.
    Petryk A; Bergemann TL; Polga KM; Ulrich KJ; Raatz SK; Brown DM; Robison LL; Baker KS
    J Clin Endocrinol Metab; 2006 Mar; 91(3):899-905. PubMed ID: 16352681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density in children with fanconi anemia after hematopoietic cell transplantation.
    Petryk A; Polgreen LE; Barnum JL; Zhang L; Hodges JS; Baker KS; Wagner JE; Steinberger J; MacMillan ML
    Biol Blood Marrow Transplant; 2015 May; 21(5):894-9. PubMed ID: 25591848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study.
    Schulte C; Beelen DW; Schaefer UW; Mann K
    Osteoporos Int; 2000; 11(4):344-53. PubMed ID: 10928225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone mineral density in inflammatory bowel diseases in children].
    Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
    Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
    Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone loss and turnover after cardiac transplantation.
    Shane E; Rivas M; McMahon DJ; Staron RB; Silverberg SJ; Seibel MJ; Mancini D; Michler RE; Aaronson K; Addesso V; Lo SH
    J Clin Endocrinol Metab; 1997 May; 82(5):1497-506. PubMed ID: 9141540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
    Arikoski P; Komulainen J; Riikonen P; Voutilainen R; Knip M; Kröger H
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral deficits in recipients of hematopoietic cell transplantation: the impact of young age at transplant.
    Petryk A; Polgreen LE; Zhang L; Hodges JS; Dengel DR; Hoffmeister PA; Steinberger J; Baker KS
    Bone Marrow Transplant; 2014 Feb; 49(2):258-63. PubMed ID: 24121211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
    Abeş M; Sarihan H; Madenci E
    J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.
    McClune BL; Polgreen LE; Burmeister LA; Blaes AH; Mulrooney DA; Burns LJ; Majhail NS
    Bone Marrow Transplant; 2011 Jan; 46(1):1-9. PubMed ID: 20729922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
    Lucidarme N; Ruiz JC; Czernichow P; Léger J
    J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation.
    Bechard LJ; Gordon C; Feldman HA; Venick R; Gura K; Guinan EC; Duggan C
    Pediatr Blood Cancer; 2015 Apr; 62(4):687-92. PubMed ID: 25630874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
    Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
    Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral disorders in pediatric and adolescent renal transplant recipients.
    Derakhshan A; Behbahan AG; Lotfi M; Omrani GH; Fallahzadeh MH; Basiratnia M; Al-Hashemi GH
    Pediatr Transplant; 2011 Jun; 15(4):367-75. PubMed ID: 21429060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U; Teichmann J; Müller-Ladner U; Strunk J
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation.
    Tauchmanovà L; Ricci P; Serio B; Lombardi G; Colao A; Rotoli B; Selleri C
    J Clin Endocrinol Metab; 2005 Feb; 90(2):627-34. PubMed ID: 15546907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.